Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Journal of Medical Virology
|
March 19, 2016
Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Cancers
|
July 27, 2022
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
Takayuki Matsumae, Takahiro Kodama, Yuta Myojin, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2021
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
Yuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 2022
Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination-authors' reply
Yuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Plos One
|
February 7, 2023
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 10, 2019
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response
Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
July 16, 2020
Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Akihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
May 13, 2010
[Investigation of simplified international diagnostic criteria for autoimmune hepatitis]
Akira Kaneko, Mitsuhiko Kubo, Ryoko Yamada, et al.
Journal of Gastroenterology
|
April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years
Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Journal of Gastroenterology
|
July 31, 2015
The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Journal of Medical Virology
|
March 19, 2016
Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Cancers
|
July 27, 2022
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
Takayuki Matsumae, Takahiro Kodama, Yuta Myojin, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2021
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
Yuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 2022
Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination-authors' reply
Yuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Plos One
|
February 7, 2023
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 10, 2019
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response
Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology
|
July 16, 2020
Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Akihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
May 13, 2010
[Investigation of simplified international diagnostic criteria for autoimmune hepatitis]
Akira Kaneko, Mitsuhiko Kubo, Ryoko Yamada, et al.
Journal of Gastroenterology
|
April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years
Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Journal of Gastroenterology
|
July 31, 2015
The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin
Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
Page
of 9